ImmuneRegen BioSciences, Inc. (IRBO) Reports Positive Results of Homspera(R) in Treating Highly Pathogenic Influenza
11/10/2009 10:56:14 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) to Further Homspera(R) Research in Study Funded by U.S. Government
10/22/2009 10:22:03 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Initiates Homspera(R) Studies Against Global Influenza Threat
10/12/2009 9:46:02 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces Strategic Partnership With Azopharma
9/23/2009 10:27:08 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces Partnership With Bachem, Inc., for Manufacturing of Homspera(R)
9/22/2009 11:10:36 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Partners With University of Rochester in BARDA Funding Bid
9/9/2009 1:25:45 PM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces Collaboration With Archimedes Development Limited
8/26/2009 10:37:27 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
7/29/2009 8:44:54 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces IND Submission for Homspera(R) for the Treatment of Idiopathic Pulmonary Fibrosis
5/28/2009 10:44:13 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO): Biotech Firm Gets Busy During Swine Flu's "Summer Vacation"
5/21/2009 12:06:59 PM
More...
|
|